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The limitations of current cancer therapies prompt the urgent need for a more effective therapeutic 
strategy [1]. Graphene-based magnetic nanoparticles (GbMNPs) due to their unique properties, 
such as high chemical and thermal stability, high charge carrier mobility, large surface area for 
functionalization and superparamagnetic properties, have the potentiality to be used as efficient 
multifunctional nanocarrier systems [2]. However, one of the challenges of GbMNPs in biomedical 
applications is their tendency for agglomeration or precipitation in electrolyte solutions, such as 
those of body fluids [3]. To overcome this drawback, the developed GbMNPs were grafted with 
copolymer Pluronic F127 (PF127), yielding the materials denoted as GbMNPs@PF127.  
PF127 is a water-soluble and biocompatible triblock copolymer (PEO100-PPO65-PEO100) approved by 
the U.S. Food and Drug Administration (FDA) for use as food additive and in pharmaceutical 
formulations [4]. This grafting strategy allows the incorporation of a hydrophilic corona that 
reduces the aggregation of nanoparticles and the adsorption of blood proteins [4, 5]. Also, increases 
the biocompatibility of the nanosystems and its colloidal stability, prolonging blood circulation [5].  
In this study, GbMNPs@PF127 were covalently conjugated with Doxorubicin (DOX), a highly 
effective chemotherapeutic drug against a broad spectrum of cancers. The developed therapeutic 
nanosystems were characterized and investigated to be used as multifunctional nanocarriers to 
combine thermo-chemotherapy, revealing exceptional features, such as: (i) high loading of the 
chemotherapeutic drug DOX; (ii) high pH stimuli-responsive controlled release; (iii) high heating 
efficiency profile under AMF with thermo-responsive drug release; as well as (iv) good haem- and 
biocompatibility even at high concentrations.  
The presented strategy and findings can represent a new way to design and synthesize highly stable 
graphene-based materials with novel structures for synergetic thermo-chemotherapy triggered by 
the abnormal cell microenvironment for a more effective treatment of cancer. 
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